Statin initiation and acute kidney injury following elective cardiovascular surgery: A population cohort study in Denmark

European Journal of Cardio-thoracic Surgery

Volumn 49, Issue 3, 2016, Pages 995-1000

  Layton, James Bradley ^a,b   Hansen, Malene K ^a   Jakobsen, Carl Johan ^a   Kshirsagar, Abhijit V ^c   Andreasen, Jan J ^d   Hjortdal, Vibeke E ^a   Rasmussen, Bodil S ^d   Simpson, Ross J ^c   Brookhart, Maurice Alan ^a,b,c   Christiansen, Christian F ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute kidney injury; Acute renal failure; Perioperative management; Surgical outcomes

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CARDIOVASCULAR SURGERY; COHORT ANALYSIS; CORONARY ARTERY BYPASS GRAFT; DENMARK; DRUG EFFECT; ELECTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SURGICAL PATIENT; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; AGED; PERIOPERATIVE PERIOD; RISK; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; CARDIOVASCULAR SURGICAL PROCEDURES; COHORT STUDIES; DENMARK; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PERIOPERATIVE PERIOD; RISK;

EID: 84962815172     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezv246     Document Type: Article

References (25)

1. Li SY, Chen JY, Yang WC, Chuang CL. Acute kidney injury network classification predicts in-hospital and long-term mortality in patients undergoing elective coronary artery bypass grafting surgery. Eur J Cardiothorac Surg 2011;39:323-8
2. Hansen MK, Gammelager H, Mikkelsen MM, Hjortdal VE, Layton JB, Johnsen SP et al. Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: a cohort study. Crit Care 2013;17:R292
3. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012;81: 442-8
4. Singh I, Rajagopalan S, Srinivasan A, Achuthan S, Dhamija P, Hota D et al. Preoperative statin therapy is associated with lower requirement of renal replacement therapy in patients undergoing cardiac surgery: a meta-analysis of observational studies. Interact CardioVasc Thorac Surg 2013;17:345-52
5. Liakopoulos Oliver J, Kuhn Elmar W, Slottosch I, Wassmer G, Wahlers T. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev 2012;4:CD008493
6. Schmidt M, Maeng M, Jakobsen CJ, Madsen M, Thuesen L, Nielsen PH et al. Existing data sources for clinical epidemiology: the Western Denmark Heart Registry. Clin Epidemiol 2010;2:137-44
7. Grann AF, Erichsen R, Nielsen AG, Froslev T, Thomsen RW. Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol 2011;3:133-8
8. Johannesdottir SA, Horvath-Puho E, Ehrenstein V, Schmidt M, Pedersen L, Sorensen HT. Existing data sources for clinical epidemiology: the Danish National Database of Reimbursed Prescriptions. Clin Epidemiol 2012;4: 303-13
9. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39:30-3
10. Dormuth CR, Patrick AR, Shrank WH, Wright JM, Glynn RJ, Sutherland J et al. Statin adherence and risk of accidents: a cautionary tale. Circulation 2009;119:2051-7
11. Group KDIGOKAKIW. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012;2:1-138
12. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13
13. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF III, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12
14. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266
15. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-06
16. Brookhart MA, Wyss R, Layton JB, Sturmer T. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes 2013;6:604-11
17. Barker N. A practical introduction to the bootstrap using the SAS system. In: Proceedings of the Pharmaceutical Users Software Exchange Conference, Paper Pk02. Heidelberg, 2005
18. Sola S, Mir MQ, Lerakis S, Tandon N, Khan BV. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 2006;47:332-7
19. Tuuminen R, Nykanen AI, Saharinen P, Gautam P, Keranen MA, Arnaudova R et al. Donor simvastatin treatment prevents ischemiareperfusion and acute kidney injury by preserving microvascular barrier function. Am J Transplant 2013;13:2019-34
20. Tadros RO, Vouyouka AG, Chung C, Malik RK, Krishnan P, Ellozy SH et al. The effect of statin use on embolic potential during carotid angioplasty and stenting. Ann Vasc Surg 2013;27:96-103
21. Sharyo S, Yokota-Ikeda N, Mori M, Kumagai K, Uchida K, Ito K et al. Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int 2008;74:577-84
22. Thomsen RW, Nielsen RB, Norgaard M, Horsdal HT, Sturmer T, Larsen FB et al. Lifestyle profile among statin users. Epidemiology 2013;24:619-20
23. Layton JB, Kshirsagar AV, Simpson RJ Jr, Pate V, Jonsson Funk M, Sturmer T et al. Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol 2013;111:823-8
24. Molnar AO, Parikh CR, Coca SG, Thiessen-Philbrook H, Koyner JL, Shlipak MG et al. Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures. Ann Thorac Surg 2014; 97:2081-7
25. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003;158:915-20